Grayscale Intervention & Diagnostics Center Private Limited
About Grayscale Intervention & Diagnostics Center Private Limited
Data last updated:
Grayscale Intervention & Diagnostics Center Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 26 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U85300RJ2020PTC068381.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tripti Shah and Geeta Chandra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 102 B – 7 Akshat Retreat Sawai Ram Singh Road Opp Sms Hospital Tonk Road, Jaipur, Rajasthan, India – 302001.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.17 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹2.97 Cr (net margin 41.4%) and EBITDA of ₹4.72 Cr (EBITDA margin 65.8%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
As per MCA filings, the company has open charges of ₹7.42 Cr and satisfied charges of ₹25.32 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address102 B – 7 Akshat Retreat Sawai Ram Singh Road Opp Sms Hospital Tonk Road, Jaipur, Rajasthan, India – 302001
- IndustryHealthcare, Medical Equipment Retail & Distribution, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Grayscale Intervention & Diagnostics Center Private Limited
The main business activity of Grayscale Intervention & Diagnostics Center is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Grayscale Intervention & Diagnostics Center Private Limited FY 2025 filings available
Grayscale Intervention & Diagnostics Center Private Limited reported revenue of ₹7.17 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Grayscale Intervention & Diagnostics Center Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years, including 1% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Grayscale Intervention & Diagnostics Center Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.72 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.97 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Grayscale Intervention & Diagnostics Center Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 65.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 41.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Grayscale Intervention & Diagnostics Center are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Grayscale Intervention & Diagnostics Center Private Limited
Grayscale Intervention & Diagnostics Center Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs, Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Konnect Diagnostics (Attapur) Private Limited | ₹7.19 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Rashi Diagnostics India Private Limited | ₹7.19 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
| Indo-American Superspecialities Private Limited | ₹7.18 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Guntur, Andhra Pradesh, India |
| Neo Alliance Healthcare Technologies Private Limited | ₹7.18 Cr (FY 2024) | •••• | •••• | 56.0% | •••• | Mumbai, Maharashtra, India |
| SRG Healthcare Private Limited | ₹7.18 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Davanagere, Karnataka, India |
| Grayscale Intervention & Diagnostics Center Private Limited this company | ₹7.17 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Jaipur, Rajasthan, India |
| KDC Lab Private Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 251.0% | •••• | Hosdurg, Kerala, India |
| Novo Healthcare Limited | ₹7.17 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | New Delhi, Delhi, India |
| Paramountcy Research and Diagnostic Centre Private Limited | ₹7.15 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Thiruvananthapuram, Kerala, India |
| Surginext Pharmaceuticals Private Limited | ₹7.15 Cr (FY 2024) | •••• | •••• | 168.0% | •••• | Delhi, India |
| Am Thyrovision Laboratories Private Limited | ₹7.13 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Grayscale Intervention & Diagnostics Center by revenue in the Healthcare industry (Diagnostics and Pathology Labs, Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Grayscale Intervention & Diagnostics Center Private Limited
Grayscale Intervention & Diagnostics Center Private Limited is audited by P C GODHA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P C GODHA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Grayscale Intervention & Diagnostics Center Private Limited
Grayscale Intervention & Diagnostics Center has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tripti Shah | Director | 26 Feb 2020 | 6 Years 7 Months | Current |
| Geeta Chandra | Director | 26 Feb 2020 | 6 Years 7 Months | Current |
Ownership and Shareholding of Grayscale Intervention & Diagnostics Center Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Grayscale Intervention & Diagnostics Center Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2022 | Others | ₹7.42 Cr | Satisfied |
| 22 Mar 2021 | Others | ₹9.9 Cr | Satisfied |
| 10 Feb 2021 | Others | ₹8 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Grayscale Intervention & Diagnostics Center Private Limited
Employment history and EPFO contributions of people linked to Grayscale Intervention & Diagnostics Center.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Grayscale Intervention & Diagnostics Center Private Limited
Grayscale Intervention & Diagnostics Center Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Rajesh Kandoi ceased to be Director on 31 Mar 2023.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Grayscale Intervention & Diagnostics Center Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Grayscale Intervention & Diagnostics Center Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Grayscale Intervention & Diagnostics Center Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Grayscale Intervention & Diagnostics Center Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Grayscale Intervention & Diagnostics Center Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Grayscale Intervention & Diagnostics Center Private Limited
Grayscale Intervention & Diagnostics Center is an active private limited company based in Jaipur, Rajasthan, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 26 February 2020 (6+ years old) and is registered under CIN U85300RJ2020PTC068381.
Grayscale Intervention & Diagnostics Center reported revenue of ₹7.17 Cr for FY 2025 (up 1% YoY).
Grayscale Intervention & Diagnostics Center has 2 current directors:
- Tripti Shah - Director
- Geeta Chandra - Director
Grayscale Intervention & Diagnostics Center reported a net profit of ₹2.97 Cr (net margin 41.4%) and EBITDA of ₹4.72 Cr (EBITDA margin 65.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Grayscale Intervention & Diagnostics Center is 13% over three years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Grayscale Intervention & Diagnostics Center is U85300RJ2020PTC068381. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grayscale Intervention & Diagnostics Center was incorporated on 26 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Grayscale Intervention & Diagnostics Center by revenue are Konnect Diagnostics (Attapur) Private Limited, Rashi Diagnostics India Private Limited, Indo-American Superspecialities Private Limited, Neo Alliance Healthcare Technologies Private Limited, SRG Healthcare Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs, Healthcare Equipment Retail and Distribution).
Rajesh Kandoi ceased to be Director on 31 Mar 2023. Geeta Chandra was appointed as Director on 26 Feb 2020. Tripti Shah was appointed as Director on 26 Feb 2020.
The registered office of Grayscale Intervention & Diagnostics Center is at 102 B – 7 Akshat Retreat Sawai Ram Singh Road Opp Sms Hospital Tonk Road, Jaipur, Rajasthan, India – 302001.
Grayscale Intervention & Diagnostics Center has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.